1 Global Biological Sample Handling Market Outlook
The global Biological Sample Handling market is anticipated to exhibit significant growth in the coming years. In 2025, the total Biological Sample Handling market value is projected to reach $1,525.45 million. This growth is underpinned by a robust compound annual growth rate (CAGR) of 7.62% from 2025 to 2030, indicating a period of substantial market development and opportunity.
Biological Sample Handling refers to the process of collecting, storing, and processing biological samples for further research or use. It plays a crucial role in various applications such as drug discovery, forensic investigation, DNA extraction, and proteomics and genomics studies. The market’s expansion is driven by the increasing demand for high-quality biological samples and the need for efficient sample management systems in the pharmaceutical and biotechnology industries.
Figure Global Biological Sample Handling Market Revenue and CAGR 2025-2030
2 Biological Sample Handling Market Dynamics
2.1 Drivers Analysis
The growth of the Biological Sample Handling market is propelled by several key factors. One of the primary drivers is the rising prevalence of diseases that require extensive research and development of new treatments. This has led to an increased demand for biological samples in drug discovery processes, where they are essential for identifying potential drug candidates and understanding disease mechanisms. Additionally, advancements in personalized and genomic medicine have created a surge in the need for precise and reliable sample handling solutions. The growing focus on precision medicine necessitates the collection and analysis of large volumes of biological samples to identify genetic markers and tailor treatments to individual patients.
Moreover, the expansion of the biotechnology and pharmaceutical industries has fueled the market’s growth. These industries are investing heavily in research and development to bring innovative therapies to market, driving the demand for efficient sample handling systems. The increasing number of clinical trials and the need for reliable data collection and storage further contribute to the market’s expansion.
2.2 Limitations Analysis
One of the primary concerns is the high cost associated with establishing and maintaining advanced sample handling facilities. The equipment, infrastructure, and skilled personnel required for effective sample management can be expensive, which may deter smaller organizations from investing in these systems. Additionally, regulatory compliance issues pose a significant challenge. The biological sample handling industry is subject to stringent regulations regarding sample collection, storage, and disposal. Ensuring compliance with these regulations can be complex and costly, potentially hindering the market’s growth.
3 Biological Sample Handling Market Technological Innovations and Corporate Mergers & Acquisitions Analysis
The Biological Sample Handling market is experiencing rapid technological advancements that are enhancing the efficiency and effectiveness of sample management systems. Innovations in storage technologies, such as the development of more efficient cold storage solutions and automated sample retrieval systems, have improved the preservation and accessibility of biological samples. These advancements allow for better sample integrity and reduce the risk of contamination or degradation, which is crucial for maintaining the reliability of research data.
Furthermore, there is a growing trend of corporate mergers and acquisitions in the market. Major players are actively engaging in strategic partnerships and acquisitions to strengthen their product portfolios and expand their market reach. For instance, Azenta Life Sciences’ acquisition of RURO Inc., a laboratory software firm, has enabled the company to offer enhanced onsite and off-site management of biological sample inventories. Such mergers and acquisitions not only consolidate market power but also facilitate the integration of complementary technologies and expertise, driving further innovation in the industry.
4 Global Biological Sample Handling Market Analysis by Type
The global Biological Sample Handling market is anticipated to witness significant growth in 2025, with various types contributing to its expansion. The market is primarily segmented into two types: Cold Storage and Room Temperature Storage. Each type plays a unique role in addressing the diverse needs of the industry.
In 2025, the Cold Storage segment is projected to dominate the market, with an estimated value of $1,327.24 million. This type of storage is crucial for preserving biological samples at low temperatures, typically ranging from -20°C to -190°C. Cold Storage is widely used for samples that require long-term preservation without degradation, such as enzymes, antibodies, and other biological reagents. The demand for Cold Storage is driven by its ability to maintain sample integrity and viability over extended periods, making it indispensable for applications in drug discovery, proteomics, and genomics research. The segment’s substantial market share of 87.01% in 2025 reflects its importance in the overall Biological Sample Handling market.
On the other hand, Room Temperature Storage is expected to have a market value of $198.21 million in 2025, accounting for a market share of 12.99%. This type of storage is suitable for biological materials that contain preservatives, such as alcohol or formalin, including specimens and tissue samples. Room Temperature Storage offers a more cost-effective solution for samples that do not require extreme temperature conditions for preservation. It is commonly used for short-term storage and transportation of samples that are stable at ambient temperatures. While it represents a smaller portion of the market compared to Cold Storage, Room Temperature Storage still plays a vital role in specific applications where temperature-controlled storage is not necessary.
Table Global Biological Sample Handling Market Size and Share by Type in 2025
|
Type |
Market Size (M USD) |
Market Share |
|---|---|---|
|
Cold Storage |
1,327.24 |
87.01% |
|
Room Temperature Storage |
198.21 |
12.99% |
5 Global Biological Sample Handling Market Analysis by Application
The global Biological Sample Handling market is anticipated to experience significant growth in 2025, with various applications contributing to its expansion. The market is segmented into several key applications, each catering to specific needs within the industry. These applications include Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, and Others. Each application plays a crucial role in driving the demand for biological sample handling solutions.
Drug Discovery
In 2025, the Drug Discovery application is expected to hold the largest market share, with a projected value of $620.52 million. Drug Discovery is a critical process in the pharmaceutical industry, involving the identification and development of new drugs to treat various diseases. Biological samples are essential in this application, as they provide valuable insights into the efficacy and safety of potential drug candidates. The increasing prevalence of diseases and the growing demand for innovative therapies drive the need for efficient sample handling systems in drug discovery research. The segment’s substantial market share of 40.68% in 2025 reflects its significance in the overall Biological Sample Handling market.
Forensic Investigation
The Forensic Investigation application is anticipated to have a market value of $81.24 million in 2025, accounting for a market share of 5.33%. Forensic Investigation relies on biological samples to aid in criminal identification, disaster victim identification, and paternity testing. The need for accurate and reliable sample analysis in forensic applications is paramount, as it can have significant legal and societal implications. The growing focus on crime prevention and the advancement of forensic technologies contribute to the demand for robust sample handling solutions in this application.
DNA Extraction
The DNA Extraction application is projected to reach a market value of $185.25 million in 2025, with a market share of 12.14%. DNA extraction is a fundamental process in molecular biology, enabling the isolation of DNA from biological samples for further analysis. This application is widely used in research, diagnostics, and personalized medicine. The increasing demand for genetic testing and the growing interest in understanding the human genome drive the need for efficient DNA extraction methods and sample handling systems.
Proteomics and Genomics Studies
The Proteomics and Genomics Studies application is expected to have a market value of $363.28 million in 2025, representing a market share of 23.81%. Proteomics and Genomics Studies involve the comprehensive analysis of proteins and genes within an organism, providing insights into biological processes and disease mechanisms. These studies require large quantities of high-quality biological samples, making sample handling a critical component of the research process. The advancement of technologies in proteomics and genomics, along with the growing emphasis on understanding the molecular basis of diseases, fuels the demand for reliable sample handling solutions in this application.
Table Global Biological Sample Handling Market Size and Share by Application in 2025
|
Application |
Market Size (M USD) |
Market Share |
|---|---|---|
|
Drug Discovery |
620.52 |
40.68% |
|
Forensic Investigation |
81.24 |
5.33% |
|
DNA Extraction |
185.25 |
12.14% |
|
Proteomics and Genomics Studies |
363.28 |
23.81% |
6 Global Biological Sample Handling Market Analysis by Region
In 2025, the United States is projected to remain the largest regional market for Biological Sample Handling, with an estimated market value of $566.47 million. This region’s dominance can be attributed to its advanced healthcare system, robust pharmaceutical and biotechnology industries, and a strong emphasis on research and development. Additionally, the region benefits from favorable funding and grants for scientific research, which further stimulates the growth of the Biological Sample Handling market. The market’s value in North America is expected to grow at a steady pace, reflecting the region’s ongoing commitment to advancing medical science and improving healthcare outcomes.
Europe is anticipated to follow closely behind North America, with a projected market value of $443.42 million in 2025. The European market benefits from a well-established healthcare infrastructure and a strong focus on precision medicine and genomics research. Countries like Germany, the United Kingdom, and France are at the forefront of adopting advanced Biological Sample Handling technologies, driven by their commitment to improving patient care and driving medical innovation. The region also hosts numerous biobanks and research centers that require efficient sample management systems. The European market’s growth is further supported by collaborative research initiatives and investments in healthcare technologies, positioning it as a key player in the global Biological Sample Handling industry.
China is poised to be the fastest-growing market for Biological Sample Handling, with a projected market value of $163.16 million in 2025. This region’s rapid growth can be attributed to several factors, including its large population, increasing prevalence of diseases, and rising healthcare expenditures. The growing demand for personalized medicine and the expansion of biotechnology industries in the region are also driving the need for efficient Biological Sample Handling solutions. Additionally, the region’s economic growth and improving healthcare infrastructure are facilitating the adoption of advanced sample management technologies, contributing to the market’s rapid expansion.
Figure Global Biological Sample Handling Revenue (M USD) by Region in 2025
7 Analysis of the Top 3 Companies in the Global Biological Sample Handling Market
7.1 Cord Blood Registry
Company Introduction and Business Overview
Cord Blood Registry, founded in 1992 and headquartered in the United States, is the largest private newborn stem cell bank in the world. The company is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today. Cord Blood Registry has helped more than 600 families use their cord blood stem cells for established and experimental medical treatments, making it a pioneer in the field of stem cell banking.
Products Offered
Cord Blood Registry offers a seamless, multi-compartment cryobag for cord blood and cord tissue samples, providing enhanced protection by reducing the potential for breakage. All samples are stored in dewars, large insulated vessels designed for long-term cryostorage, in a vapor-phase environment kept at minus 196 degrees Celsius. The company’s storage facility is located in Tucson, Arizona, which has a low risk of natural disasters, ensuring the safety and integrity of the samples.
Sales Revenue in 2022
In 2022, Cord Blood Registry generated a revenue of $113.78 million. This revenue reflects the company’s strong market position and the increasing demand for cord blood banking services among parents seeking to secure potential future treatments for their children.
7.2 Azenta Life Sciences (Brooks Automation)
Company Introduction and Business Overview
Azenta Life Sciences, formerly known as Brooks Automation, is a leading provider of life sciences solutions worldwide. The company enables impactful breakthroughs and therapies to market faster by offering a full suite of reliable cold-chain sample management solutions and genomic services. Azenta Life Sciences serves top pharmaceutical, biotech, academic, and healthcare institutions globally, focusing on areas such as drug development, clinical research, and advanced cell therapies.
Products Offered
Azenta Life Sciences provides a range of Biological Sample Handling products, including ultra-low temperature freezers, cryogenic storage systems, and automated sample management solutions. These products are designed to meet the stringent requirements of the life sciences industry, ensuring the preservation and integrity of biological samples throughout the research and development process.
Sales Revenue in 2022
In 2022, Azenta Life Sciences reported a revenue of $99.06 million from its Biological Sample Handling business. This revenue highlights the company’s success in providing innovative and reliable solutions to its diverse clientele in the life sciences sector.
7.3 Discovery Life Sciences
Company Introduction and Business Overview
Discovery Life Sciences, established in 2018, is a leading provider of highly characterized human biospecimens and cellular starting materials integrated with expert multi-omic analytical services. The company accelerates cell and gene therapy and precision medicine programs for cancer, infectious disease, and other complex conditions by offering a comprehensive range of biospecimen and biomarker solutions.
Products Offered
Discovery Life Sciences combines the world’s largest commercial biospecimen inventory and procurement network with preeminent multi-omic service laboratories. The company offers a wide array of products, including fresh and cryopreserved human cellular materials, tissue microarrays, and various other biospecimens. These products are supported by extensive pathology information and patient clinical history documentation, making them invaluable for researchers in the fields of oncology, neurology, immunology, and more.
Sales Revenue in 2022
In 2022, Discovery Life Sciences achieved a revenue of $69.02 million from its Biological Sample Handling operations. This revenue underscores the company’s rapid growth and its ability to meet the evolving needs of the biopharmaceutical and research communities.